| MeSH term | MeSH ID | Detail |
|---|---|---|
| Angina Pectoris | D000787 | 27 associated lipids |
| Angina Pectoris, Variant | D000788 | 3 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Hypoxia | D000860 | 23 associated lipids |
| Aortic Aneurysm | D001014 | 8 associated lipids |
| Aortic Arch Syndromes | D001015 | 2 associated lipids |
| Aortic Rupture | D001019 | 3 associated lipids |
| Arrhythmias, Cardiac | D001145 | 42 associated lipids |
| Arterial Occlusive Diseases | D001157 | 12 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ohsaki S et al. | Effect of prostaglandin E1 on graft function of kidneys from living related donors. | 1992 | Transpl. Int. | pmid:14621746 |
| Schütz A et al. | Allogeneic heart transplantation following xenogeneic bridging. | 1992 | Transpl. Int. | pmid:14621808 |
| Yamada K et al. | New morphological changes induced by FK506 in a short period in the rat kidney and the effect of superoxide dismutase and OKY-046 on THEM: the relationship of FK506 nephrotoxicity to lipid peroxidation and change in production of thromboxane A2 in the kidney. | 1992 | Transpl. Int. | pmid:14621878 |
| Mennander A et al. | Chronic rejection of rat aortic allografts: effect of inhibition of the thromboxane cascade. | 1992 | Transpl. Int. | pmid:14621882 |
| Gianello P et al. | Measurement of the vasoconstrictive substances endothelin, angiotensin II, and thromboxane B2 in cold storage solution can reveal previous renal ischemic insults. | 1994 | Transpl. Int. | pmid:8117396 |
| Torras J et al. | Renal protective effect of liposomed superoxide dismutase in an experimental warm ischemia model. | 1994 | Transpl. Int. | pmid:11271283 |
| Yokoyama I et al. | Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation. | 1996 | Transpl. Int. | pmid:8748415 |
| van Marwijk Kooy M et al. | Filtration. A method to prepare white cell-poor platelet concentrates with optimal preservation of platelet viability. | 1990 | Transfusion | pmid:2296787 |
| Valeri CR et al. | Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. | 2001 | Transfusion | pmid:11493727 |
| Böck M et al. | Storage of single-donor platelet concentrates: metabolic and functional changes. | 1993 | Transfusion | pmid:8480351 |
| Hansen TN and Brockbank KG | Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists. | 1997 | Transfusion | pmid:9225932 |
| van Prooijen HC et al. | Differences in the susceptibility of platelets to freezing damage in relation to size. | 1989 Jul-Aug | Transfusion | pmid:2526399 |
| Stuart MJ | The effect of irradiation on platelet arachidonic acid metabolism. | 1983 Mar-Apr | Transfusion | pmid:6404019 |
| Wallvik J et al. | The effect of different agitation modes on platelet metabolism, thromboxane formation, and alpha-granular release during platelet storage. | 1990 | Transfusion | pmid:2119532 |
| Menitove JE et al. | Use of PGE1 for preparation of platelet concentrates. | 1986 Jul-Aug | Transfusion | pmid:2941906 |
| Menitove JE et al. | Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. | 1984 Nov-Dec | Transfusion | pmid:6390814 |
| Valeri CR et al. | Circulation and hemostatic function of autologous fresh, liquid-preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy. | 2002 | Transfusion | pmid:12430680 |
| Boeri N et al. | Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma. | 1994 | Transfusion | pmid:7940660 |
| Güllner HG et al. | Correction of increased prostacyclin production in Bartter's syndrome by indomethacin. | 1980 | Trans. Assoc. Am. Physicians | pmid:7018063 |
| Di Minno G et al. | In vivo platelet activation in homozygous cystathionine beta-synthase deficiency: a probucol-sensitive phenomenon. | 1992 | Trans. Assoc. Am. Physicians | pmid:1308991 |
| Tobian L et al. | Prostaglandin alterations in barely hypertensive Dahl S rats. | 1985 | Trans. Assoc. Am. Physicians | pmid:3842205 |
| Bito LZ | Prostaglandins and other eicosanoids: their ocular transport, pharmacokinetics, and therapeutic effects. | 1986 | Trans Ophthalmol Soc U K | pmid:3541303 |
| Zapol WM et al. | Plasma thromboxane and prostacyclin metabolites in sheep partial cardiopulmonary bypass. | 1980 | Trans Am Soc Artif Intern Organs | pmid:7018060 |
| Westenfelder C et al. | Renal function in calves with total artificial hearts. | 1985 | Trans Am Soc Artif Intern Organs | pmid:3837477 |
| Wonders TR et al. | Reduced plasma thromboxane elevation during partial cardiopulmonary bypass in thrombocytopenic sheep. | 1981 | Trans Am Soc Artif Intern Organs | pmid:7331082 |
| Song YM et al. | Effects of scorpion venom bioactive polypolypeptides on platelet aggregation and thrombosis and plasma 6-keto-PG F1alpha and TXB2 in rabbits and rats. | 2005 | Toxicon | pmid:15975616 |
| Huang HC | Release of slow reacting substance from the guinea-pig lung by phospholipases A2 of Vipera russelli snake venom. | 1984 | Toxicon | pmid:6206608 |
| Al-Hassan JM et al. | Vasoconstrictor components in the Arabian Gulf catfish (Arius thalassinus, Ruppell) proteinaceous skin secretion. | 1986 | Toxicon | pmid:3824400 |
| Chan CP et al. | Inhibition of cyclooxygenase activity, platelet aggregation and thromboxane B2 production by two environmental toxicants: m- and o-cresol. | 2005 | Toxicology | pmid:15664436 |
| Mayer AM et al. | Cyanobacterial Microcystis aeruginosa lipopolysaccharide elicits release of superoxide anion, thromboxane Bâ‚‚, cytokines, chemokines, and matrix metalloproteinase-9 by rat microglia. | 2011 | Toxicol. Sci. | pmid:21362633 |
| Mayer AM et al. | Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro. | 2016 | Toxicol. Sci. | pmid:26609141 |
| Ren R et al. | Protective effects of Danshensu on liver injury induced by omethoate in rats. | 2010 | Toxicol. Mech. Methods | pmid:20843270 |
| Leung LK and Glauert HP | Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate. | 1996 | Toxicol. Lett. | pmid:8644126 |
| Ferrari D et al. | Cyanidin-3-O-glucoside inhibits NF-kB signalling in intestinal epithelial cells exposed to TNF-α and exerts protective effects via Nrf2 pathway activation. | 2016 | Toxicol. Lett. | pmid:27793764 |
| McKinnon KP et al. | In vitro ozone exposure increases release of arachidonic acid products from a human bronchial epithelial cell line. | 1993 | Toxicol. Appl. Pharmacol. | pmid:8442000 |
| Carpenter LJ and Roth RA | Involvement of thromboxane in injury to isolated rat lungs perfused with phorbol myristate acetate in the presence and absence of neutrophils. | 1987 | Toxicol. Appl. Pharmacol. | pmid:3672516 |
| Sahota T et al. | Model-based analysis of thromboxane Bâ‚‚ and prostaglandin Eâ‚‚ as biomarkers in the safety evaluation of naproxen. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24667227 |
| Eisenmann CJ and Miller RK | The effect of selenium compounds (selenite, selenate, ebselen) on the production of thromboxane and prostacyclin by the human term placenta in vitro. | 1995 | Toxicol. Appl. Pharmacol. | pmid:7482536 |
| Fujimoto Y et al. | Effects of endocrine disruptors on arachidonic acid metabolism in rabbit platelets. | 2003 | Toxicol. Appl. Pharmacol. | pmid:12781627 |
| Ganey PE and Roth RA | 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole. | 1987 | Toxicol. Appl. Pharmacol. | pmid:3564035 |
| Miller PD et al. | Effect of ozone exposure on lung functions and plasma prostaglandin and thromboxane concentrations in guinea pigs. | 1987 | Toxicol. Appl. Pharmacol. | pmid:3470978 |
| Yarom R et al. | The effect of T-2 toxin on human platelets. | 1984 | Toxicol. Appl. Pharmacol. | pmid:6710522 |
| Santostefano MJ et al. | Off-target platelet activation in macaques unique to a therapeutic monoclonal antibody. | 2012 | Toxicol Pathol | pmid:22552394 |
| Nakazawa I et al. | Some features of the metastatic cancer cells in prostaglandin production. | 1989 | Tohoku J. Exp. Med. | pmid:2510366 |
| Watanabe J et al. | Effect of vitamin E on platelet aggregation in diabetes mellitus. | 1984 | Tohoku J. Exp. Med. | pmid:6474447 |
| Watanabe J et al. | Effect of prostaglandin synthetase inhibitors on platelet aggregation and thromboxane production in diabetes mellitus. | 1984 | Tohoku J. Exp. Med. | pmid:6515648 |
| Nakazawa I et al. | Some features in prostaglandin synthesis of the cancer cells which metastasized into liver from intestinal cancer lesions. | 1993 | Tohoku J. Exp. Med. | pmid:8266326 |
| Tomita Y et al. | Leukotrienes and thromboxane B2 stimulate normal human melanocytes in vitro: possible inducers of postinflammatory pigmentation. | 1988 | Tohoku J. Exp. Med. | pmid:3252558 |
| Perkett EA et al. | Lymphocyte and granulocyte migration across the endothelial layer of bovine pulmonary artery intimal explants towards lymphocyte conditioned medium. | 1986 | Tissue Cell | pmid:3810636 |
| Wallis RB | Mechanisms of action of sulphinpyrazone. | 1983 | Thromb. Res. Suppl. | pmid:6415857 |